Parinam advises non-promoter shareholders of Emcure Pharmaceuticals in their offer for sale at the IPO

Description

Parinam advised the non-promoter shareholders of Emcure Pharmaceuicals on selling their shares in the IPO (Offer for Sale)

News & Media

$275 million equity infusion for Essar’s GreenLine Mobility – Times of Indiaillion-equity-infusion-for-essars-greenline-mobility/amp_articleshow/120171012.cms

Mint Explainer: Why Byju’s creditors have dragged its insolvency professional to court | Company Business News

Rising vigilance from producers to combat digital piracy and merchandise theft | Mint

Centre’s lateral entry policy corrects a historical wrong | The Indian Express

Secular Civil Code will unify, not divide Indians | The Indian Express

Dear Editor, I Disagree: Maharashtra’s ‘Urban Naxal’ law is not aimed at silencing dissent | The Indian Express